Okano et al. [25] have identified a CTL epitope in the IL-13Rα2 chain by in vitro stimulation of dendritic cells with synthetic peptides, implying that this receptor chain might serve as a tumor antigen inducing CTL. This evidence concerns the gene IL13RA2 and neoplasm.